108 related articles for article (PubMed ID: 20103692)
1. Homogeneous GTP binding assay employing QRET technology.
Rozwandowicz-Jansen A; Laurila J; Martikkala E; Frang H; Hemmilä I; Scheinin M; Hänninen P; Härmä H
J Biomol Screen; 2010 Mar; 15(3):261-7. PubMed ID: 20103692
[TBL] [Abstract][Full Text] [Related]
2. Europium-labeled GTP as a general nonradioactive substitute for [(35)S]GTPgammaS in high-throughput G protein studies.
Koval A; Kopein D; Purvanov V; Katanaev VL
Anal Biochem; 2010 Feb; 397(2):202-7. PubMed ID: 19849998
[TBL] [Abstract][Full Text] [Related]
3. A homogeneous single-label time-resolved fluorescence cAMP assay.
Martikkala E; Rozwandowicz-Jansen A; Hänninen P; Petäjä-Repo U; Härmä H
J Biomol Screen; 2011 Mar; 16(3):356-62. PubMed ID: 21343601
[TBL] [Abstract][Full Text] [Related]
4. [³⁵S]GTPγS binding as an index of total G-protein and Gα-subtype-specific activation by GPCRs.
Mistry R; Dowling MR; Challiss RA
Methods Mol Biol; 2011; 746():263-75. PubMed ID: 21607862
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.
Peters MF; Knappenberger KS; Wilkins D; Sygowski LA; Lazor LA; Liu J; Scott CW
J Biomol Screen; 2007 Apr; 12(3):312-9. PubMed ID: 17307886
[TBL] [Abstract][Full Text] [Related]
6. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
7. Comparison of homogeneous single-label fluorometric binding assays: fluorescence polarization and dual-parametric quenching resonance energy transfer technique.
Härmä H; Sarrail G; Kirjavainen J; Martikkala E; Hemmilä I; Hänninen P
Anal Chem; 2010 Feb; 82(3):892-7. PubMed ID: 20047278
[TBL] [Abstract][Full Text] [Related]
8. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
9. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
10. Nonradioactive GTP binding assay to monitor activation of g protein-coupled receptors.
Frang H; Mukkala VM; Syystö R; Ollikka P; Hurskainen P; Scheinin M; Hemmilä I
Assay Drug Dev Technol; 2003 Apr; 1(2):275-80. PubMed ID: 15090192
[TBL] [Abstract][Full Text] [Related]
11. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
12. [35S]GTPgammaS binding in G protein-coupled receptor assays.
Cooper T; McMurchie EJ; Leifert WR
Methods Mol Biol; 2009; 552():143-51. PubMed ID: 19513647
[TBL] [Abstract][Full Text] [Related]
13. Homogeneous single-label biochemical Ras activation assay using time-resolved luminescence.
Martikkala E; Veltel S; Kirjavainen J; Rozwandowicz-Jansen A; Lamminmäki U; Hänninen P; Härmä H
Anal Chem; 2011 Dec; 83(24):9230-3. PubMed ID: 22098697
[TBL] [Abstract][Full Text] [Related]
14. Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay.
Engström M; Närvänen A; Savola JM; Wurster S
Peptides; 2004 Dec; 25(12):2099-104. PubMed ID: 15572197
[TBL] [Abstract][Full Text] [Related]
15. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
[TBL] [Abstract][Full Text] [Related]
16. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
17. A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discovery.
Labrecque J; Wong RS; Fricker SP
Methods Mol Biol; 2009; 552():153-69. PubMed ID: 19513648
[TBL] [Abstract][Full Text] [Related]
18. Measurement of agonist-stimulated [35S]GTPgammaS binding to assess total G-protein and Galpha-subtype-specific activation by G-protein-coupled receptors.
Dowling MR; Nahorski SR; Challiss RA
Methods Mol Biol; 2004; 259():197-206. PubMed ID: 15250494
[TBL] [Abstract][Full Text] [Related]
19. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
Pauwels PJ; Tardif S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
[TBL] [Abstract][Full Text] [Related]
20. A new simple cell-based homogeneous time-resolved fluorescence QRET technique for receptor-ligand interaction screening.
Härmä H; Rozwandowicz-Jansen A; Martikkala E; Frang H; Hemmilä I; Sahlberg N; Fey V; Perälä M; Hänninen P
J Biomol Screen; 2009 Sep; 14(8):936-43. PubMed ID: 19684287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
